|
US5059591B1
(en)
|
1983-05-26 |
2000-04-25 |
Liposome Co Inc |
Drug preparations of reduced toxicity
|
|
US5571714A
(en)
|
1988-12-22 |
1996-11-05 |
Celtrix Pharmaceuticals, Inc. |
Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use
|
|
US6124449A
(en)
|
1990-06-11 |
2000-09-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands and inhibitors
|
|
US5731144A
(en)
|
1990-06-11 |
1998-03-24 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands
|
|
US5731424A
(en)
|
1990-06-11 |
1998-03-24 |
Nexstar Pharmaceuticals, Inc. |
High affinity TGFβ nucleic acid ligands and inhibitors
|
|
US5561163A
(en)
|
1990-08-31 |
1996-10-01 |
Deprenyl Animal Health, Inc. |
Treating hearing loss with deprenyl
|
|
US5421818A
(en)
|
1993-10-18 |
1995-06-06 |
Inner Ear Medical Delivery Systems, Inc. |
Multi-functional inner ear treatment and diagnostic system
|
|
GB9601081D0
(en)
|
1995-10-06 |
1996-03-20 |
Cambridge Antibody Tech |
Specific binding members for human transforming growth factor beta;materials and methods
|
|
US5837681A
(en)
|
1996-02-23 |
1998-11-17 |
Amgen Inc. |
Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product
|
|
US6593290B1
(en)
|
1996-11-01 |
2003-07-15 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
|
US6045528A
(en)
|
1997-06-13 |
2000-04-04 |
Intraear, Inc. |
Inner ear fluid transfer and diagnostic system
|
|
US6806358B1
(en)
|
1997-12-16 |
2004-10-19 |
University Of California San Diego |
Peptide inhibitor of TGF-β growth factors
|
|
US6177434B1
(en)
|
1997-12-16 |
2001-01-23 |
The United States Of America As Represented By The Secretary Of The Navy |
Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms
|
|
AU760046B2
(en)
|
1998-02-27 |
2003-05-08 |
United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
|
|
GB9809869D0
(en)
|
1998-05-09 |
1998-07-08 |
Medical Res Council |
Inhibition of protein kinases
|
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
ES2146552B1
(es)
|
1998-11-24 |
2001-04-16 |
Inst Cientifico Tecnol Navarra |
Peptidos inhibidores de tgf/31
|
|
AU4206200A
(en)
|
1999-04-05 |
2000-10-23 |
Adherex Technologies Inc. |
Compounds and methods for stimulating beta-catenin mediated gene expression and differentiation
|
|
US6492497B1
(en)
|
1999-04-30 |
2002-12-10 |
Cambridge Antibody Technology Limited |
Specific binding members for TGFbeta1
|
|
DE60129222T2
(de)
|
2000-05-11 |
2008-03-06 |
Consejo Superior de Investigaciónes Científicas |
Heterocyclischen inhibitoren von glycogen synthase kinase gsk-3
|
|
US6509318B1
(en)
|
2000-09-29 |
2003-01-21 |
The Regents Of The University Of California |
TGF-B inhibitors and methods
|
|
US20050287128A1
(en)
|
2001-05-18 |
2005-12-29 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)
|
|
US20050227936A1
(en)
|
2001-05-18 |
2005-10-13 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of TGF-beta and TGF-beta receptor gene expression using short interfering nucleic acid (siNA)
|
|
SI1397364T1
(sl)
|
2001-05-24 |
2007-12-31 |
Lilly Co Eli |
Novi pirolni derivati kot farmacevtske uäśinkovine
|
|
US20030028905A1
(en)
|
2001-07-31 |
2003-02-06 |
Petra Knaus |
Mutant forms of the TGF-beta type II receptor which bind all TGF-beta isoforms
|
|
IL161662A0
(en)
|
2001-11-01 |
2004-09-27 |
Janssen Pharmaceutica Nv |
Heteroaryl amines as glycogen synthase kinase 3 beta inhibitors (gsk3 inhibitors)
|
|
SE0200979D0
(sv)
|
2002-03-28 |
2002-03-28 |
Astrazeneca Ab |
New compounds
|
|
US20040006030A1
(en)
|
2002-07-02 |
2004-01-08 |
Isis Pharmaceuticals Inc. |
Antisense modulation of TGF-beta 2 expression
|
|
JP2005530800A
(ja)
|
2002-05-15 |
2005-10-13 |
スミスクライン・ビーチャム・コーポレイション |
ベンゾオキサジンおよびベンゾオキサジノン置換トリアゾール
|
|
AU2003229305A1
(en)
|
2002-05-17 |
2003-12-02 |
Scios, Inc. |
TREATMENT OF FIBROPROLIFERATIVE DISORDERS USING TGF-Beta INHIBITORS
|
|
US7190468B2
(en)
|
2002-07-17 |
2007-03-13 |
Hewlett-Packard Development Company, L.P. |
Background document rendering system and method
|
|
EP1539748A1
(en)
|
2002-07-31 |
2005-06-15 |
Smithkline Beecham Corporation |
2-phenylpyridin-4-yl derivatives as alk5 inhibitors
|
|
EP1739087A1
(en)
|
2002-08-02 |
2007-01-03 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of gsk-3
|
|
MXPA05001367A
(es)
|
2002-08-02 |
2005-04-28 |
Vertex Pharma |
Composiciones de pirazol utiles como inhibidores de gsk-3.
|
|
UA80296C2
(en)
|
2002-09-06 |
2007-09-10 |
Biogen Inc |
Imidazolopyridines and methods of making and using the same
|
|
WO2004026871A1
(en)
|
2002-09-17 |
2004-04-01 |
Eli Lilly And Company |
Novel pyrazolopyridine derivatves as pharmaceutical agents
|
|
KR20050057441A
(ko)
|
2002-09-18 |
2005-06-16 |
화이자 프로덕츠 인코포레이티드 |
전환 성장 인자 억제제로서의 신규한 아이소티아졸 및아이속사졸 화합물
|
|
JP2006502236A
(ja)
|
2002-09-18 |
2006-01-19 |
ファイザー・プロダクツ・インク |
形質転換成長因子（ｔｇｆ）阻害剤としてのトリアゾール誘導体
|
|
WO2004047818A2
(en)
|
2002-11-22 |
2004-06-10 |
Scios, Inc. |
USE OF TFG-β INHIBITORSTO COUNTERACT PATHOLOGIC CHANGES IN THE LEVEL OR FUNCTION OF STEROID/THYROID RECEPTORS
|
|
JP2006516603A
(ja)
|
2003-01-27 |
2006-07-06 |
ファイザー・プロダクツ・インク |
イソチアゾール誘導体
|
|
DE602004014347D1
(de)
|
2003-03-12 |
2008-07-24 |
Millennium Pharm Inc |
Chinazolin-derivate als tgf-beta-inhibitoren
|
|
EP1608631A4
(en)
|
2003-03-28 |
2008-08-20 |
Scios Inc |
BICYCLIC PYRIMIDININHIBITORS OF TGF BETA
|
|
ES2389258T3
(es)
|
2003-06-17 |
2012-10-24 |
Millennium Pharmaceuticals, Inc. |
Composiciones y métodos para inhibir TGF-s
|
|
WO2005009287A2
(en)
|
2003-07-21 |
2005-02-03 |
University Of Maryland, Baltimore |
Drug delivery to the inner ear and methods of using same
|
|
SG145713A1
(en)
|
2003-08-13 |
2008-09-29 |
Univ Illinois |
SILENCING OF TGFss TYPE II RECEPTOR EXPRESSION BY SIRNA
|
|
JP4688680B2
(ja)
|
2003-10-28 |
2011-05-25 |
独立行政法人理化学研究所 |
ＴＧＦ−β情報伝達経路阻害剤
|
|
US8673634B2
(en)
|
2003-11-13 |
2014-03-18 |
Massachusetts Eye & Ear Infirmary |
Method for the treatment of hearing loss
|
|
GB0327908D0
(en)
|
2003-12-02 |
2004-01-07 |
Neuropharma Sa |
GSK-3 inhibitors isolated from marine organisms
|
|
CA2551524A1
(en)
|
2003-12-24 |
2005-07-21 |
Scios, Inc. |
Treatment of malignant gliomas with tgf-beta inhibitors
|
|
US7368445B2
(en)
|
2004-03-01 |
2008-05-06 |
Eli Lilly And Company |
Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms
|
|
AR048335A1
(es)
|
2004-03-24 |
2006-04-19 |
Chugai Pharmaceutical Co Ltd |
Agentes terapeuticos para trastornos del oido interno que contienen un antagonista de il- 6 como un ingrediente activo
|
|
WO2005115527A2
(en)
|
2004-05-24 |
2005-12-08 |
Auris Medical, Llc. |
Combined otic aspirator and medication dispenser
|
|
GB0418328D0
(en)
|
2004-08-17 |
2004-09-22 |
Imp College Innovations Ltd |
Cancer methods and medicaments
|
|
JP2007176795A
(ja)
|
2004-08-18 |
2007-07-12 |
Univ Nihon |
ＴＧＦ−β遺伝子発現抑制剤
|
|
WO2006034207A2
(en)
|
2004-09-17 |
2006-03-30 |
Vanderbilt University |
Use of gsk3 inhibitors in combination with radiation therapies
|
|
CA2597098C
(en)
|
2005-02-08 |
2016-08-02 |
Steven R. Ledbetter |
Antibodies to tgfbeta
|
|
GB0505970D0
(en)
|
2005-03-23 |
2005-04-27 |
Univ Edinburgh |
Culture medium containing kinase inhibitor, and uses thereof
|
|
CN101189234B
(zh)
|
2005-03-25 |
2011-08-17 |
泰博特克药品有限公司 |
Hcv的杂二环抑制剂
|
|
DK1864132T3
(da)
|
2005-03-31 |
2012-07-16 |
Stemnion Inc |
Fra amnion stammende cellesammensætninger, fremgangsmåder til fremstilling deraf og anvendelser deraf
|
|
UA92608C2
(en)
|
2005-06-30 |
2010-11-25 |
Янссен Фармацевтика Н.В. |
Cyclic anilino - pyridinotriazines as gsk-3 inhibitors
|
|
CA2616196C
(en)
|
2005-07-22 |
2012-08-21 |
Eli Lilly And Company |
A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor
|
|
EP1749523A1
(en)
|
2005-07-29 |
2007-02-07 |
Neuropharma, S.A. |
GSK-3 inhibitors
|
|
CA2625883A1
(en)
|
2005-10-14 |
2007-04-26 |
Regents Of The University Of Minnesota |
Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
|
|
AU2005337776B2
(en)
|
2005-10-24 |
2013-01-31 |
Proyecto De Biomedicina Cima, S.L. |
Use of TGF-Beta1 inhibitor peptides in the preparation of an immune response modulating agent
|
|
US7951845B2
(en)
|
2006-01-19 |
2011-05-31 |
The Regents Of The University Of Michigan |
Composition and method of treating hearing loss
|
|
ITMI20060181A1
(it)
|
2006-02-03 |
2007-08-04 |
Univ Padova |
Modulatori del tgf-b e loro uso
|
|
TW200800203A
(en)
|
2006-03-08 |
2008-01-01 |
Astrazeneca Ab |
New use
|
|
WO2007109097A2
(en)
|
2006-03-16 |
2007-09-27 |
Alnylam Pharmaceuticals, Inc. |
RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF
|
|
ES2725601T3
(es)
|
2006-04-28 |
2019-09-25 |
Lifescan Inc |
Diferenciación de células madre embriónicas humanas
|
|
CA2661334C
(en)
|
2006-08-23 |
2011-11-29 |
Pfizer Products Inc. |
Pyrimidone compounds as gsk-3 inhibitors
|
|
WO2008076556A2
(en)
|
2006-11-15 |
2008-06-26 |
Massachusetts Eye & Ear Infirmary |
Generation of inner ear cells
|
|
CA2673368C
(en)
|
2006-12-19 |
2014-10-28 |
The Board Of Trustees Of The University Of Illinois |
3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders
|
|
WO2009017453A1
(en)
|
2007-07-30 |
2009-02-05 |
Astrazeneca Ab |
New therapeutic combination of an antipsychotic and a gsk3 inhibitor 958
|
|
WO2009017455A1
(en)
|
2007-07-30 |
2009-02-05 |
Astrazeneca Ab |
A new combination of (a) an alpha-4-beta-2 -neuronal nicotinic agonist and (b) a gsk3 inhibitor
|
|
EP2197876A1
(en)
|
2007-08-29 |
2010-06-23 |
Glaxosmithkline LLC |
Thiazole and oxazole kinase inhibitors
|
|
US8377886B2
(en)
|
2007-09-14 |
2013-02-19 |
Albert Einstein College Of Medicine Of Yeshiva University |
Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal disease
|
|
JP5951254B2
(ja)
*
|
2008-03-17 |
2016-07-13 |
ザ スクリプス リサーチ インスティテュート |
人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法
|
|
WO2009132050A2
(en)
|
2008-04-21 |
2009-10-29 |
Otonomy, Inc. |
Auris formulations for treating otic diseases and conditions
|
|
US20090270497A1
(en)
|
2008-04-24 |
2009-10-29 |
Pharmacyclics, Inc. |
Treatment of Non-Localized Inflammation with pan-HDAC Inhibitors
|
|
WO2009142719A2
(en)
|
2008-05-19 |
2009-11-26 |
Massachusetts Institute Of Technology |
Tympanic membrane permeating ear drops and uses thereof
|
|
WO2010011466A2
(en)
|
2008-06-27 |
2010-01-28 |
Otonomy, Inc. |
Controlled-release cns modulating compositions and methods for the treatment of otic disorders
|
|
US8496957B2
(en)
|
2008-07-21 |
2013-07-30 |
Otonomy, Inc |
Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
|
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
|
US20120059021A1
(en)
*
|
2008-11-11 |
2012-03-08 |
University Of Washington |
Compositions and methods for treating cancer and methods for predicting a response to such treatments
|
|
WO2010060088A2
(en)
*
|
2008-11-24 |
2010-05-27 |
Massachusetts Eye & Ear Infirmary |
Pathways to generate hair cells
|
|
EP2376626A4
(en)
|
2008-12-13 |
2012-10-17 |
Dna Microarray |
MICRO-ENVIRONMENTAL NICHE ASSAY FOR SCREENING OF INDUCED PLURIPOTENT STEM CELLS (CIPS)
|
|
US20130039998A1
(en)
|
2008-12-24 |
2013-02-14 |
University Of Washington |
Compositions of modulators of the wnt/beta-catenin pathway and benzamide and/or hydroxamic acid derivatives to treat bipolar disorder
|
|
US8642339B2
(en)
|
2009-02-03 |
2014-02-04 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Culture medium for epithelial stem cells and organoids comprising the stem cells
|
|
GB201111244D0
(en)
|
2011-06-30 |
2011-08-17 |
Konink Nl Akademie Van Wetenschappen Knaw |
Culture media for stem cells
|
|
US9752124B2
(en)
|
2009-02-03 |
2017-09-05 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Culture medium for epithelial stem cells and organoids comprising the stem cells
|
|
EP2412800A1
(en)
*
|
2010-07-29 |
2012-02-01 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Liver organoid, uses thereof and culture method for obtaining them
|
|
CA2755120C
(en)
|
2009-03-11 |
2017-05-16 |
Kyorin Pharmaceutical Co., Ltd. |
7-cycloalkylaminoquinolones as gsk-3 inhibitors
|
|
WO2011019957A1
(en)
|
2009-08-12 |
2011-02-17 |
University Of Southern California |
Method for formation of induced pluripotent stem cells
|
|
LT2494039T
(lt)
|
2009-10-31 |
2019-07-25 |
Genesis Technologies Limited |
Ląstelių perprogramavimo būdai ir jų panaudojimas
|
|
US20110135756A1
(en)
|
2009-12-08 |
2011-06-09 |
University Of Washington |
Compositions and methods for protecting sensory hair cells
|
|
CA2785233C
(en)
|
2009-12-28 |
2018-10-09 |
Audiocure Pharma Gmbh |
.beta.-carbolines for treatment of hearing damages and vertigo
|
|
US8198285B2
(en)
|
2010-01-19 |
2012-06-12 |
Astrazeneca Ab |
Pyrazine derivatives
|
|
WO2011116930A1
(en)
|
2010-03-22 |
2011-09-29 |
Cellartis Ab |
Directed differentiation and maturation of pluripotent cells into hepatocyte like cells by modulation of wnt-signalling pathway
|
|
CA2800498C
(en)
|
2010-03-31 |
2021-11-16 |
The Scripps Research Institute |
Reprogramming cells
|
|
ES2705236T3
(es)
|
2010-05-12 |
2019-03-22 |
Univ Columbia |
Procedimientos para producir células enteroendocrinas que producen y secretan insulina
|
|
CN103459591B
(zh)
|
2010-11-02 |
2016-05-04 |
国立大学法人熊本大学 |
肠细胞的制造方法
|
|
EP2667881A4
(en)
|
2011-01-24 |
2015-04-22 |
Univ Leland Stanford Junior |
METHOD FOR IN VITRO GENERATION OF INTERNAL CELLS
|
|
KR101807704B1
(ko)
|
2011-04-12 |
2017-12-13 |
차의과학대학교 산학협력단 |
역분화-증진제를 이용한 역분화 만능 줄기세포의 제조방법
|
|
HUE041576T2
(hu)
*
|
2011-09-14 |
2019-05-28 |
Samumed Llc |
Indazol-3-karboxamid-származékok és alkalmazásuk Wnt/b-katenin szignalizáló útvonal inhibitorokként
|
|
EP2765188B1
(en)
|
2011-10-06 |
2017-12-06 |
Keio University |
Method for producing corneal endothelial cell
|
|
EP2838888B1
(en)
|
2012-02-24 |
2017-04-12 |
ASD Therapeutics Partners LLC |
Thiadiazolidinediones as gsk-3 inhibitors
|
|
US9457009B2
(en)
|
2012-05-31 |
2016-10-04 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Methods and compositions for preventing and treating auditory dysfunctions
|
|
TW201406758A
(zh)
|
2012-06-28 |
2014-02-16 |
Daiichi Sankyo Co Ltd |
三環性化合物
|
|
GB201212960D0
(en)
|
2012-07-20 |
2012-09-05 |
Common Services Agency |
Erythroid production
|
|
CA2884309A1
(en)
*
|
2012-09-07 |
2014-03-13 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for regenerating hair cells and/or supporting cells from differentiated cochlear cells or differentiated utricular cells by modulation of notch and cmyc activity
|
|
WO2014050779A1
(ja)
|
2012-09-25 |
2014-04-03 |
第一三共株式会社 |
Ｇｓｋ３阻害剤と抗ｄｒ５抗体の組み合わせ
|
|
DK2909204T3
(en)
|
2012-10-12 |
2019-04-01 |
Broad Inst Inc |
GSK3 INHIBITORS AND METHODS FOR USE THEREOF
|
|
CN105143445B
(zh)
|
2012-11-29 |
2020-07-07 |
宝生物欧洲公司 |
衍生自人多能干细胞的肝细胞样细胞的成熟
|
|
US20140248696A1
(en)
|
2013-03-01 |
2014-09-04 |
Wisconsin Alumni Research Foundation |
Methods of maintaining, expanding, and diffrentiating neuronal subtype specific progenitors
|
|
BR112015023261A2
(pt)
|
2013-03-14 |
2017-07-18 |
Massachusetts Inst Technology |
composições e métodos para expansão e cultura de células-tronco epiteliais
|
|
WO2015168149A2
(en)
*
|
2014-04-28 |
2015-11-05 |
Massachusetts Eye & Ear Infirmary |
Sensorineural hair cell differentiation
|
|
US10457915B2
(en)
|
2014-05-15 |
2019-10-29 |
International Stem Cell Corporation |
Chemical differentiation of pluripotentstem cells into retinal epithelial cells
|
|
CN107073042A
(zh)
|
2014-09-03 |
2017-08-18 |
布里格海姆妇女医院公司 |
用于产生内耳毛细胞来治疗听力损失的组合物、系统和方法
|
|
CN104726395B
(zh)
|
2015-03-20 |
2018-03-23 |
深圳市人民医院 |
一种诱导人诱导多能干细胞定向分化为胰腺细胞的方法
|
|
GB201505605D0
(en)
|
2015-03-31 |
2015-05-13 |
Univ Sheffield |
Method for producing otic progenitors
|
|
EP3350313B1
(en)
|
2015-09-15 |
2025-11-26 |
Agency For Science, Technology And Research (A*star) |
Derivation of liver organoids from human pluripotent stem cells
|
|
CA3010610A1
(en)
|
2016-01-08 |
2017-07-13 |
The Brigham And Women's Hospital, Inc. |
Production of differentiated enteroendocrine cells and insulin producing cells
|
|
WO2019183572A1
(en)
|
2018-03-23 |
2019-09-26 |
Refuge Biotechnologies, Inc. |
Gene regulation via conditional nuclear localization of gene modulating polypeptides
|